Published data suggested that the presence of EMM resulted in a strong trend toward a shorter duration of response than that of classic MM despite treatment with novel drugs ( 8 , 9 ).
← all excerpts
Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature.
1
—
—